{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:52:09Z","timestamp":1759963929924,"version":"3.41.2"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T00:00:00Z","timestamp":1602547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2020.562074","type":"journal-article","created":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T13:45:07Z","timestamp":1602596707000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["Expression of P16INK4a in Uveal Melanoma: New Perspectives"],"prefix":"10.3389","volume":"10","author":[{"given":"Daniela","family":"Russo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa Maria","family":"Di Crescenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Broggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Merolla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Martino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Varricchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gennaro","family":"Ilardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Borzillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella","family":"Carandente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Pignatiello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Mascolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosario","family":"Caltabiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Staibano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,10,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.2147\/OPTH.S113623","article-title":"Trends in incidence, survival, and management of uveal melanoma: a population-based study of 7,516 patients from the surveillance, epidemiology, and end results database (1973\u20132012).","volume":"10","author":"Mahendraraj","year":"2016","journal-title":"Clin Ophthalmol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10555-017-9663-3","article-title":"The biology of uveal melanoma.","volume":"36","author":"Amaro","year":"2017","journal-title":"Cancer Metastasis Rev."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11071032","article-title":"So close, yet so far: discrepancies between uveal and other melanomas. a position paper from UM cure 2020.","volume":"11","author":"Rodrigues","year":"2019","journal-title":"Cancers."},{"key":"B4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2741\/e60","article-title":"CXCR4-CXCL12 and VEGF correlate to uveal melanoma progression.","volume":"2","author":"Franco","year":"2010","journal-title":"Front Biosci."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1177\/1758834018757175","article-title":"Treatment of uveal melanoma: where are we now?","author":"Yang","year":"","journal-title":"Ther Adv Med Oncol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers11050694","article-title":"New insights into molecular oncogenesis and therapy of uveal melanoma.","volume":"11","author":"Violanti","year":"2019","journal-title":"Cancers."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11081061","article-title":"Molecular characteristics of uveal melanoma: insights from the cancer genome atlas (TCGA) project.","volume":"11","author":"Bakhoum","year":"2019","journal-title":"Cancers."},{"key":"B8","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(18)31559-9","article-title":"Melanoma.","volume":"392","author":"Schadendorf","year":"2018","journal-title":"Lancet."},{"key":"B9","doi-asserted-by":"publisher","first-page":"646","DOI":"10.6004\/jnccn.2018.0042","article-title":"New NCCN guidelines for uveal melanoma and treatment of recurrent or progressive distant metastatic melanoma.","volume":"16","author":"Barker","year":"2018","journal-title":"J Natl Compr Cancer Netw."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00198","article-title":"Systemic therapy for melanoma: ASCO guideline.","author":"Seth","year":"","journal-title":"J Clin Oncol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1038\/sj.onc.1202737","article-title":"Tissue-specific alternative splicing in the human INK4a\/ARF cell cycle regulatory locus.","volume":"18","author":"Robertson","year":"1999","journal-title":"Oncogene."},{"key":"B12","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1136\/jclinpath-2018-205216","article-title":"P16.","volume":"71","author":"Serra","year":"2018","journal-title":"J Clin Pathol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.suc.2019.09.005","article-title":"Epidemiology and risk factors of melanoma.","volume":"100","author":"Carr","year":"2020","journal-title":"Surg Clin North Am."},{"key":"B14","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/cup.13350","article-title":"Immunohistochemistry of p16 in nevi of pregnancy and nevoid melanomas.","volume":"45","author":"Koh","year":"2018","journal-title":"J Cutan Pathol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"815","DOI":"10.5858\/arpa.2017-0435-RA","article-title":"Immunohistochemical expression of p16 in melanocytic lesions: an updated review and meta-analysis.","volume":"142","author":"Koh","year":"2018","journal-title":"Arch Pathol Lab Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1097\/PAI.0000000000000511","article-title":"Diagnostic algorithm combining immunohistochemistry and molecular cytogenetics to diagnose challenging melanocytic tumors.","volume":"26","author":"Redon","year":"2018","journal-title":"Appl Immunohistochem Mol Morphol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/ijd.12386","article-title":"Ocular melanoma and the BAP1 hereditary cancer syndrome: implications for the dermatologist.","volume":"53","author":"Martorano","year":"2014","journal-title":"Int J Dermatol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"377","DOI":"10.18388\/abp.2002_3796","article-title":"Expression of p16 in sporadic primary uveal melanoma.","volume":"49","author":"Lamperska","year":"2002","journal-title":"Acta Biochim Pol."},{"key":"B19","first-page":"4320","article-title":"Inactivation of retinoblastoma protein in uveal melanoma by phosphorylation of sites in the COOH-terminal region.","volume":"60","author":"Brantley","year":"2000","journal-title":"Cancer Res."},{"key":"B20","first-page":"779","article-title":"Analysis of p16 (CDKN2\/MTS-1\/INK4A) alterations in primary sporadic uveal melanoma.","volume":"40","author":"Merbs","year":"1999","journal-title":"Investig Ophthalmol Vis Sci."},{"key":"B21","first-page":"5303","article-title":"Promoter hypermethylation: a common cause of reduced p16INK4a expression in uveal melanoma.","volume":"61","author":"Van der Veiden","year":"2001","journal-title":"Cancer Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1083\/jcb.200410115","article-title":"MITF links differentiation with cell cycle arrest in melanocytes by transcriptional activation of INK4A.","volume":"168","author":"Loercher","year":"2005","journal-title":"J Cell Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2147\/TACG.S69210","article-title":"The genetics of uveal melanoma: current insights.","volume":"9","author":"Helgadottir","year":"2016","journal-title":"Appl Clin Genet."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15606-0","article-title":"Molecular profiling of driver events in metastatic uveal melanoma.","volume":"11","author":"Karlsson","year":"2020","journal-title":"Nat Commun."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/s41588-019-0440-9","article-title":"The genetic evolution of metastatic uveal melanoma.","volume":"51","author":"Shain","year":"2019","journal-title":"Nat Genet."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/s0002-9440(10)64817-1","article-title":"Deregulation of the Rb and p53 pathways in uveal melanoma.","volume":"157","author":"Brantley","year":"2000","journal-title":"Am J Pathol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/978-1-62703-287-2_2","article-title":"Tissue microarrays: construction and use.","volume":"980","author":"Remotti","year":"2013","journal-title":"Methods Mol Biol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1136\/jclinpath-2017-204387","article-title":"Immunohistochemistry on old archival paraffin blocks: is there an expiry date?","volume":"70","author":"Grillo","year":"2017","journal-title":"J Clin Pathol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00418-015-1316-4","article-title":"Factors affecting immunoreactivity in long-term storage of formalin-fixed paraffin-embedded tissue sections.","volume":"144","author":"Grillo","year":"2015","journal-title":"Histochem Cell Biol."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis.","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1001\/jamaophthalmol.2018.2466","article-title":"Survival rates in patients after treatment formetastasis from uveal melanoma.","volume":"136","author":"Lane","year":"2018","journal-title":"JAMA Ophthalmol."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2990.2012.01255.x","article-title":"Eye pathology: an atlas and text.","volume":"38","author":"Eagle","year":"2011","journal-title":"JAMA J Am Med Assoc."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2015.566","article-title":"Diagnostic value of SOX-10 immunohistochemical staining for the detection of uveal melanoma.","volume":"9","author":"Alghamdi","year":"2015","journal-title":"Ecancermedicalscience."},{"key":"B34","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2147\/OPTH.S89591","article-title":"Uveal melanoma: epidemiology, etiology, and treatment of primary disease.","volume":"11","author":"Krantz","year":"2017","journal-title":"Clin Ophthalmol."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.19037.1","article-title":"Recent advances in tissue imaging for cancer research [version 1; peer review: 2 approved].","volume":"8","author":"Maiques","year":"2019","journal-title":"F1000Research."},{"key":"B36","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10585-018-9893-y","article-title":"Genetics of metastasis: melanoma and other cancers.","volume":"35","author":"Turner","year":"2018","journal-title":"Clin Exp Metastasis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.4161\/cc.10.15.16776","article-title":"The meaning of p16ink4a expression in tumors: functional significance, clinical associations and future developments.","volume":"10","author":"Witkiewicz","year":"2011","journal-title":"Cell Cycle."}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.562074\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T13:45:10Z","timestamp":1602596710000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.562074\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,13]]},"references-count":37,"alternative-id":["10.3389\/fonc.2020.562074"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.562074","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2020,10,13]]},"article-number":"562074"}}